Eugene Schneider sold $1.2M of IONS
EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC. 19,658 shares at an average of $60.81, traded Sep 3, 2025, filed Sep 4, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1.2M at market
- +10Share of holdings soldSold 28% of holdings
- +15Cluster13 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874015-25-000211, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 3, 2025 | MOption exercise Common Stock10b5-1 | +19,658 | $53.77 | $1.1M | 71,165 | Sep 4, 2025 |
| Sep 3, 2025 | SOpen-market sale Common Stock10b5-1 | -12,455 | $60.46 | $753k | 58,710 | Sep 4, 2025 |
| Sep 3, 2025 | SOpen-market sale Common Stock10b5-1 | -7,203 | $61.42 | $442k | 51,507 | Sep 4, 2025 |
| Sep 3, 2025 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -19,658 | $0.00 | $0 | 0 | Sep 4, 2025 |
Related signals
Other insiders at IONIS PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $609k 8,000 shares | -14% | |
| 23Weak | IONIS PHARMACEUTICALS INC | Brian Birchler EVP, Corp and Development Ops | $1.7M 23,900 shares | -35% | |
| 13Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $113k 1,625 shares | -5% | |
| 23Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $1.0M 15,000 shares | -32% | |
| 5Weak | IONIS PHARMACEUTICALS INC | Patrick R. O'Neil EVP CLO & General Counsel | $110k 1,700 shares | -3% | |
| 26Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $743k 11,950 shares | -27% | |
| 30Weak | IONIS PHARMACEUTICALS INC | Patrick R. O'Neil EVP CLO & General Counsel | $1.4M 21,000 shares | -27% | |
| 25Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $358k 6,000 shares | -7% | |
| 0Weak | IONIS PHARMACEUTICALS INC | Joseph Baroldi EVP, Chief Business Officer | $16k 250 shares | -1% | |
| 30Weak | IONIS PHARMACEUTICALS INC | C Frank Bennett EVP, Chief Scientific Officer | $2.3M 38,909 shares | -42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.